• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • Custom Kit Production
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • MEMORYLINC
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
  • IFU APO-Easy
  • Copy of IFU APO-Easy
  • Stability APO-Easy
  • APO-Easy-FLS-OE02-01
  • APO-Easy-FLS-OE02-02
  • APO-Easy-FLS-OE02-03
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media
RNAs to predict COVID-19's cardiovascular outcomes

RNAs to predict COVID-19's cardiovascular outcomes

Check out the video presentation of our COVIRNA project, in which, 15 European partners from healthcare, academia and industry, collaborate around the objective of generating an innovative diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications in the context of the current pandemic, in order to improve their surveillance and care.

 

https://www.youtube.com/watch?v=-dFSqFm1mUU&t=2s

 

The COVIRNA project is based on FIRALIS’ innovative “FIMICS panel” (click to know more on FIMICS) of cardiac enriched long non-coding RNAs (“lncRNA”s) and coordinated by the Luxembourg Institute of Health (“LIH”). For more information on COVIRNA project, check our press release here and the consortium website here : https://covirna.eu/

19.07.2021

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE